相关实验视频
Updated: Jul 26, 2025

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
94.6K
超胰岛素血症是否可能是Erysichthon神话背后的临床解释?
1Bachelor of Doctor Assistance Department, DDT College of Medicine, Gaborone, Botswana. asaniotis@ddtcollegeofmedicine.com.
Acta diabetologica
|June 12, 2023
概括
这项研究探讨了Erysichthon的古老神话,表明他的症状可能表明胰岛素瘤,一种罕见的胰腺瘤导致低血糖症. 这些发现凸显了这种内分泌疾病的潜在诊断挑战.
科学领域:
- 内分泌学 在内分泌学.
- 医学史 医学史 医学史
- 经典研究是古典研究.
背景情况:
- 胰岛素瘤是一种罕见的胰腺β细胞瘤,患病率为100万分之四.
- 典型的特征是高胰岛素血糖低血症,症状包括神经糖分和catecholamine反应.
- 由于症状与其他疾病重叠,往往在诊断上具有挑战性.
研究的目的:
- 为了检查古希腊的Erysichthon神话.
- 推测Erysichthon所描述的症状与高胰岛素症的症状之间的潜在关系.
主要方法:
- 从古典来源 (黑西奥德,卡利马克斯,欧维迪乌斯) 来对埃里西希通神话进行审查和分析.
- 对Erysichthon报告的症状与胰岛素瘤的临床表现进行比较检查.
主要成果:
- 埃里西赫顿的症状,包括焦虑和异常行为,与胰岛素瘤中观察到的交上腺和神经糖效应一致.
- 神话描述了Erysichthon的瘦弱尽管多,反映了一些胰岛素瘤病例的体重减轻.
- 胰岛素瘤的诊断挑战是由神经系统疾病的症状重叠所强调的.
结论:
- 在Erysichthon神话中描述的临床症状表明可能,尽管是推测性的,与胰岛素瘤有关.
- 虽然在古代,胰岛素瘤是未知的,但Erysichthon的呈现值得考虑这种内分泌瘤.
相关概念视频
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin: Dosing Regimen and Adverse Effects
215
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
215
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Insulin: Biosynthesis, Chemistry, and Preparation
442
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
442

